ArticleThe Journal of antimicrobial chemotherapy2016

Dolutegravir-based monotherapy or dual therapy maintains a high proportion of viral suppression even in highly experienced HIV-1-infected patients.

Camelia Gubavu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.